Subscribe To
Tips and short-term bonds garnering investor funds
Morningstar data shows that market conditions didn't turn investors away from bonds in 2021 with Treasu...
January 24, 2022, 1:44 pm
Tips and short-term bonds garnering investor funds
Morningstar data shows that market conditions didn't turn investors away from bonds in 2021 with Treasu...
January 24, 2022, 1:44 pm
Clean energy stocks down but not out
Last year saw a raft of investment into sustainable funds and climate technology, but market conditions ...
January 24, 2022, 11:43 am
Clean energy stocks down but not out
Last year saw a raft of investment into sustainable funds and climate technology, but market conditions ...
January 24, 2022, 11:43 am
Clean energy stocks down but not out
Last year saw a raft of investment into sustainable funds and climate technology, but market conditions ...
January 24, 2022, 11:43 am
Where will amc stock be in 5 years? assuming favorable conditions, multiverse of possibilities
2021 marked when AMC added cryptocurrencies to its balance sheet since it announced it will accept cryptocurrency for online ticketing and concession ...
January 24, 2022, 9:45 am
Where will amc stock be in 5 years? assuming favorable conditions, multiverse of possibilities
2021 marked when AMC added cryptocurrencies to its balance sheet since it announced it will accept cryptocurrency for online ticketing and concession ...
January 24, 2022, 9:45 am
Where will amc stock be in 5 years? assuming favorable conditions, multiverse of possibilities
2021 marked when AMC added cryptocurrencies to its balance sheet since it announced it will accept cryptocurrency for online ticketing and concession ...
January 24, 2022, 9:45 am
Ntsx: excessively risky under current market conditions
NTSX is a leveraged balanced equity and treasury index ETF....
January 24, 2022, 8:32 am
Ntsx: excessively risky under current market conditions
NTSX is a leveraged balanced equity and treasury index ETF....
January 24, 2022, 8:32 am
Ntsx: excessively risky under current market conditions
NTSX is a leveraged balanced equity and treasury index ETF....
January 24, 2022, 8:32 am
3 profitable businesses with solid financial conditions
When screening the market for value opportunities, investors may want to consider stocks that represent companies with high profitability and robust f...
January 21, 2022, 12:31 pm
3 profitable businesses with solid financial conditions
When screening the market for value opportunities, investors may want to consider stocks that represent companies with high profitability and robust f...
January 21, 2022, 12:31 pm
3 profitable businesses with solid financial conditions
When screening the market for value opportunities, investors may want to consider stocks that represent companies with high profitability and robust f...
January 21, 2022, 12:31 pm
Will lower consolidated revenues hurt at&t (t) q4 earnings?
In the fourth quarter, AT&T (T) is likely to have recorded lower revenues year over year despite improving market ...
January 21, 2022, 11:35 am
Will lower consolidated revenues hurt at&t (t) q4 earnings?
In the fourth quarter, AT&T (T) is likely to have recorded lower revenues year over year despite improving market ...
January 21, 2022, 11:35 am
Will lower consolidated revenues hurt at&t (t) q4 earnings?
In the fourth quarter, AT&T (T) is likely to have recorded lower revenues year over year despite improving market ...
January 21, 2022, 11:35 am
Kaleido biosciences to present updated data of kb295 in ulcerative colitis at the 2022 crohn's and colitis congress
LEXINGTON, Mass., Jan. 21, 2022 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage biotech company with a differentiated, ...
January 21, 2022, 11:04 am
Kaleido biosciences to present updated data of kb295 in ulcerative colitis at the 2022 crohn's and colitis congress
LEXINGTON, Mass., Jan. 21, 2022 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage biotech company with a differentiated, ...
January 21, 2022, 11:04 am
Kaleido biosciences to present updated data of kb295 in ulcerative colitis at the 2022 crohn's and colitis congress
LEXINGTON, Mass., Jan. 21, 2022 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage biotech company with a differentiated, ...
January 21, 2022, 11:04 am